Press Release •  2023-10-03

Corteva Agriscience Announces Commercial Launch of Straxan™ Fungicide Seed Treatment

Something went wrong. Please try again later...

The new treatment for cereal grains provides powerful protection against early-season seed and seedling diseases

CALGARY, AB, October 4, 2023 – Corteva, Inc. (NYSE: CTVA) today announced the commercial launch of Straxan™ fungicide seed treatment in Canada, bringing farmers a new, ready-to-use and easy-to-apply formulation that targets prominent seed and soil-borne cereal diseases.

The latest offering from Corteva Agriscience’s leading cereal protection portfolio, Straxan fungicide seed treatment provides advanced protection against early season diseases – such as Fusarium species, Rhizoctonia, true loose smut and more – to help maximize crop stand establishment and yield potential. This level of protection is a result of Straxan fungicide seed treatment’s high-quality formulation of proven active ingredients.

“Protecting yield potential from persistent diseases will always be a priority for cereal farmers, which is why it was important for us to bring a complete and versatile option like Straxan fungicide seed treatment to the Western Canadian market,” said Kirsten Ratzlaff, Portfolio Manager, Seed Applied Technologies & Biologicals, Corteva Agriscience. “In addition to its strong disease protection, Straxan offers an easy-to-apply formulation that provides flexibility – both through commercial seed treaters and on-farm equipment – and stable application under varying conditions and temperatures.''

Straxan fungicide seed treatment is a highly compatible formulation and can be used with multiple seed treatment products. This includes Lumivia™ CPL insecticide seed treatment, which delivers the broadest cereal seedling insect protection on the market for long-lasting control of wireworms, cutworms and more. When mixed with Straxan fungicide seed treatment, farmers get a complete cereal seed treatment package.

“Seed treatments help crops get off to their best possible start, and Corteva continues to invest in R&D to deliver robust seed treatment offerings to Canadian farmers,” said Ratzlaff. “Straxan fungicide seed treatment fortifies Corteva’s industry-leading cereal protection portfolio, equipping farmers with a tool that will help each seed reach its genetic potential.”

Learn more about Straxan fungicide seed treatment at straxan.corteva.ca

About Corteva Agriscience 
Corteva, Inc. (NYSE: CTVA) is a publicly traded, global pure-play agriculture company that combines industry-leading innovation, high-touch customer engagement and operational execution to profitably deliver solutions for the world’s most pressing agriculture challenges. Corteva generates advantaged market preference through its unique distribution strategy, together with its balanced and globally diverse mix of seed, crop protection, and digital products and services. With some of the most recognized brands in agriculture and a technology pipeline well positioned to drive growth, the company is committed to maximizing productivity for farmers, while working with stakeholders throughout the food system as it fulfills its promise to enrich the lives of those who produce and those who consume, ensuring progress for generations to come. More information can be found at www.corteva.com.

Corteva Agriscience is a member of Excellence Through Stewardship® (ETS). Corteva Agriscience products are commercialized in accordance with ETS Product Launch Stewardship Guidance and in compliance with the Corteva Agriscience policies regarding stewardship of those products. In line with these guidelines, our product launch process for responsible launches of new products includes a longstanding process to evaluate export market information, value chain consultations, and regulatory functionality. Growers and end-users must take all steps within their control to follow appropriate stewardship requirements and confirm their buyer’s acceptance of the grain or other material being purchased. For more detailed information on the status of a trait or stack, please visit www.biotradestatus.com.

Follow Corteva on Facebook, Instagram, LinkedIn, Twitter, and YouTube.

 

Cautionary Statement on Forward-Looking Statements

This release contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like “plans,” “expects,” “will,” “anticipates,” “believes,” “intends,” or other words of similar meaning. All statements that address expectations or projections about the future, including statements about Corteva’s expectations related to regulatory approvals, product development, product offerings and product, financial or sustainability performance are forward-looking statements. Corteva disclaims and does not undertake any obligation to update or revise any forward-looking statement, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements or other estimates is included in the “Risk Factors” section of Corteva’s Annual Report on Form 10-K, as modified by subsequent reports on Form 10-Q and Current Reports on Form 8-K.